Cargando…

Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetes

BACKGROUND: Weight loss (WL) is an independent predictor of mortality in patients with heart failure (HF). Moderate WL is recommended for overweight or obese patients with type 2 diabetes mellitus (DM). The aim of this study was to assess the prognostic impact of body weight reduction on survival in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niedziela, Jacek T., Hudzik, Bartosz, Strojek, Krzysztof, Poloński, Lech, Gąsior, Mariusz, Rozentryt, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903445/ https://www.ncbi.nlm.nih.gov/pubmed/31397095 http://dx.doi.org/10.1002/jcsm.12471

Ejemplares similares

The obesity paradox in acute coronary syndrome: a meta-analysis
por: Niedziela, Jacek, et al.
Publicado: (2014)

Lancisi sign: giant C-V waves of tricuspid regurgitation
por: Hudzik, Bartosz, et al.
Publicado: (2016)

Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients
por: Myrda, Krzysztof, et al.
Publicado: (2015)

CHA(2)DS(2)-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation
por: Hudzik, Bartosz, et al.
Publicado: (2016)

Higher Serum Phosphorus Is Not an Independent Risk Factor of Mortality in Heart Failure with Reduced Ejection Fraction
por: Robert, Partyka, et al.
Publicado: (2021)

Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure
por: Rozentryt, Piotr, et al.
Publicado: (2015)

Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure
por: Kurczyński, Dominik, et al.
Publicado: (2022)

Single nucleotide polymorphisms for genes encoding cytokines in the context of cardiac surgery. Part I: Heart transplantation
por: Danikiewicz, Aleksander, et al.
Publicado: (2015)

Testing for antiphospholipid antibodies at autopsy
por: Hudzik, Bartosz, et al.
Publicado: (2014)

The Association between Serum Levels of 25[OH]D, Body Weight Changes and Body Composition Indices in Patients with Heart Failure
por: Stefaniak, Apolonia, et al.
Publicado: (2020)

Pericardial tamponade as a complication of invasive cardiac procedures: a review of the literature
por: Adamczyk, Maria, et al.
Publicado: (2019)

Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients
por: Romuk, Ewa, et al.
Publicado: (2020)

Death without Previous Hospital Readmission in Patients with Heart Failure with Reduced Ejection Fraction—A New Endpoint from Old Clinical Trials
por: Niedziela, Jacek T., et al.
Publicado: (2022)

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

The role of balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation
por: Wacławski, Jacek, et al.
Publicado: (2015)

Gender-related disparities in the treatment and outcomes in patients with non-ST-segment elevation myocardial infarction: results from the Polish Registry of Acute Coronary Syndromes (PL-ACS) in the years 2012–2014
por: Piątek, Łukasz, et al.
Publicado: (2020)

Spot Urinary Creatinine Concentration in Patients with Chronic Heart Failure Identifies a Distinct Muscle-Wasting Phenotype with a Strikingly Different Risk of Mortality
por: Malinowska-Borowska, Jolanta, et al.
Publicado: (2023)

Associations of changes in patient characteristics and management with decrease in mortality rates of men and women with ST-elevation myocardial infarction – a propensity score-matched analysis
por: Zandecki, Lukasz, et al.
Publicado: (2020)

Aortic balloon valvuloplasty as a bridge-to-decision in patients with aortic stenosis
por: Wacławski, Jacek, et al.
Publicado: (2019)

Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
por: Gąsior, Paweł, et al.
Publicado: (2013)

The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction
por: Birkner, Katarzyna, et al.
Publicado: (2017)

Metabolic and genetic profiling of young adults with and without a family history of premature coronary heart disease (MAGNETIC). Study design and methodology
por: Osadnik, Tadeusz, et al.
Publicado: (2019)

Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021)

The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study
por: Rozentryt, Piotr, et al.
Publicado: (2010)

Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions
por: Zandecki, Łukasz, et al.
Publicado: (2019)

Higher mortality in women after ST-segment elevation myocardial infarction in very young patients
por: Sadowski, Marcin, et al.
Publicado: (2013)

Von Willebrand factor in patients on mechanical circulatory support – a double-edged sword between bleeding and thrombosis
por: Hudzik, Bartosz, et al.
Publicado: (2015)

Monitoring hemostasis parameters in left ventricular assist device recipients – a preliminary report
por: Hudzik, Bartosz, et al.
Publicado: (2016)

Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction
por: Kurdziel, Marta, et al.
Publicado: (2021)

Comment on ‘Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetes’ by Niedziela et al.
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Prognostic Value of Spot Urinary Creatinine Concentration and Its Relationship with Body Composition Parameters in HF Patients
por: Malinowska-Borowska, Jolanta, et al.
Publicado: (2023)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
por: Gąsior, Paweł, et al.
Publicado: (2018)

Comparison of outcomes in patients undergoing rotational atherectomy after unsuccessful coronary angioplasty versus elective rotational atherectomy
por: Gorol, Jaroslaw, et al.
Publicado: (2018)

The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention
por: Osadnik, Tadeusz, et al.
Publicado: (2017)

Mechanical circulatory support in cardiogenic shock – what every interventional cardiologist should know
por: Pyka, Łukasz, et al.
Publicado: (2014)

Paramedic versus physician-staffed ambulances and prehospital delays in the management of patients with ST-segment elevation myocardial infarction
por: Borowicz, Artur, et al.
Publicado: (2021)

Myocardial Infarction in Centenarians. Data from The Polish Registry of Acute Coronary Syndromes
por: Piegza, Jacek, et al.
Publicado: (2020)

Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy
por: Wojciechowska, Celina, et al.
Publicado: (2021)

The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention
por: Desperak, Piotr, et al.
Publicado: (2022)

The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively
por: Mazurek, Michal, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sti4n1o86ai8t6vev7h2ibbreo